145 related articles for article (PubMed ID: 33166845)
1. An allomaltol derivative triggers distinct death pathways in luminal a and triple-negative breast cancer subtypes.
Ercan A; Oncul S; Karakaya G; Aytemir M
Bioorg Chem; 2020 Dec; 105():104403. PubMed ID: 33166845
[TBL] [Abstract][Full Text] [Related]
2. Small Molecular Leads Differentially Active Against HER2 Positive and Triple Negative Breast Cancer Cell Lines.
Badran A; Atia-Tul-Wahab ; Fayyaz S; Baydoun E; Choudhary MI
Med Chem; 2019; 15(7):738-742. PubMed ID: 30398120
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Molecular Mechanism of Cinnamic Acid-Mediated Cytotoxicity in Triple Negative MDA-MB-231 Breast Cancer Cells.
Pal A; Tapadar P; Pal R
Anticancer Agents Med Chem; 2021; 21(9):1141-1150. PubMed ID: 32767960
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
Luo Y; Wu W; Zha D; Zhou W; Wang C; Huang J; Chen S; Yu L; Li Y; Huang Q; Zhang J; Zhang C
Bioorg Med Chem Lett; 2021 Sep; 47():128230. PubMed ID: 34186178
[TBL] [Abstract][Full Text] [Related]
5. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
Sambi M; Samuel V; Qorri B; Haq S; Burov SV; Markvicheva E; Harless W; Szewczuk MR
Drug Des Devel Ther; 2020; 14():1995-2019. PubMed ID: 32546966
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
[TBL] [Abstract][Full Text] [Related]
7. A styrylpyrone dimer isolated from Aniba heringeri causes apoptosis in MDA-MB-231 triple-negative breast cancer cells.
de Souza KFS; Tófoli D; Pereira IC; Filippin KJ; Guerrero ATG; Paredes-Gamero EJ; de Fatima Cepa Matos M; Garcez WS; Garcez FR; Perdomo RT
Bioorg Med Chem; 2021 Feb; 32():115994. PubMed ID: 33477019
[TBL] [Abstract][Full Text] [Related]
8. Novel racemosin B derivatives as new therapeutic agents for aggressive breast cancer.
Xiao X; Xu M; Yang C; Yao Y; Liang LN; Ed Chung P; Long Q; Zacksenhaus E; He Z; Liu S; Ben-David Y
Bioorg Med Chem; 2018 Dec; 26(23-24):6096-6104. PubMed ID: 30471828
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel dipeptidyl boronic acid proteasome inhibitor for the treatment of multiple myeloma and triple-negative breast cancer.
Lei M; Feng H; Bai E; Zhou H; Wang J; Qin Y; Zhang H; Wang X; Liu Z; Hai O; Liu J; Zhu Y
Org Biomol Chem; 2019 Jan; 17(3):683-691. PubMed ID: 30601533
[TBL] [Abstract][Full Text] [Related]
10. Novel Thiazolidinone/Thiazolo[3,2-
El-Naggar M; Eldehna WM; Almahli H; Elgez A; Fares M; Elaasser MM; Abdel-Aziz HA
Molecules; 2018 Jun; 23(6):. PubMed ID: 29895744
[TBL] [Abstract][Full Text] [Related]
11. The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways.
Almalki E; Al-Amri A; Alrashed R; Al-Zharani M; Semlali A
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298600
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and structure-activity relationship studies of a focused library of pyrimidine moiety with anti-proliferative and anti-metastasis activities in triple negative breast cancer.
Yao D; Zhou Y; Zhu L; Ouyang L; Zhang J; Jiang Y; Zhao Y; Sun D; Yang S; Yu Y; Wang J
Eur J Med Chem; 2017 Nov; 140():155-171. PubMed ID: 28923383
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of Novel Methyl 3-(hetero)arylthieno[3,2-
Silva BR; Rebelo R; Rodrigues JM; Xavier CPR; Vasconcelos MH; Queiroz MRP
Molecules; 2021 Mar; 26(6):. PubMed ID: 33805741
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the Effects and Mechanisms of Anticancer Action of a Ru(II)-Arene Iminophosphorane Compound in Triple Negative Breast Cancer Cells.
Nayeem N; Yeasmin A; Cobos SN; Younes A; Hubbard K; Contel M
ChemMedChem; 2021 Nov; 16(21):3280-3292. PubMed ID: 34329530
[TBL] [Abstract][Full Text] [Related]
15. A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistance.
Oncul S; Karakaya G; Dilsiz Aytemir M; Ercan A
Chem Biol Drug Des; 2019 Dec; 94(6):2084-2093. PubMed ID: 31495064
[TBL] [Abstract][Full Text] [Related]
16. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
17. One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells.
Eldehna WM; El-Naggar DH; Hamed AR; Ibrahim HS; Ghabbour HA; Abdel-Aziz HA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):309-318. PubMed ID: 29281924
[TBL] [Abstract][Full Text] [Related]
18. Sophoridine Derivatives Induce Apoptosis and Autophagy to Suppress the Growth of Triple-Negative Breast Cancer through Inhibition of mTOR Signaling.
Dai L; Wang L; Tan C; Cai J; Shen H; Zhang T; Zhi S; Yang Z; Hu Y; Zhao X; Li D
ChemMedChem; 2022 Jan; 17(1):e202100434. PubMed ID: 34569159
[TBL] [Abstract][Full Text] [Related]
19. Cepharanthine sensitizes human triple negative breast cancer cells to chemotherapeutic agent epirubicin via inducing cofilin oxidation-mediated mitochondrial fission and apoptosis.
Shen LW; Jiang XX; Li ZQ; Li J; Wang M; Jia GF; Ding X; Lei L; Gong QH; Gao N
Acta Pharmacol Sin; 2022 Jan; 43(1):177-193. PubMed ID: 34294886
[TBL] [Abstract][Full Text] [Related]
20. Activation of Intrinsic Apoptosis and G1 Cell Cycle Arrest by a Triazole Precursor, N-(4-chlorophenyl)-2-(4-(3,4,5-trimethoxybenzyloxy)benzoyl)-hydrazinecarbothioamide in Breast Cancer Cell Line.
Arulnathan SB; Leong KH; Ariffin A; Kareem HS; Cheah KKH
Anticancer Agents Med Chem; 2020; 20(9):1072-1086. PubMed ID: 32188392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
